Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A or Prevenar™ Co-administered With Hiberix™

NCT00680914 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00680914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00680914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A or Prevenar™ Co-administered With Hiberix™
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
June 10, 2008
Completion date
May 8, 2009
Enrollment
503 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

infections, streptococcal